MedTrace Logo

PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.

NCT06247163 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-09-27

No results posted yet for this study

Summary

There is a prospective risk-adapted evaluation of the optimal dose of radiotherapy for definitive radiotherapy of locally advanced small cell lung cancer within the corridor recommended as standard therapy according to the current interdisciplinary S3 guideline of the German Cancer Society/Cancer Aid/AWMF

Conditions

  • Small Cell Lung Carcinoma

Interventions

RADIATION

PET based Raditherapy boost

An Interim PET CT will be performed. If there is residual vital tumor, a higher radiation dose will be applied.

Sponsors & Collaborators

  • University Hospital, Essen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-22
Primary Completion
2025-06-22
Completion
2029-06-22

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06247163 on ClinicalTrials.gov